Vimarsana
Biggest News Aggregation in the World

Page 2 - Il 17 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Il 17. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Il 17 Today - Breaking & Trending Today

With Little Remaining Unmet Need for Injectable Biologics - Vimarsana News

With Little Remaining Unmet Need for Injectable Biologics

Despite the increased efficacy of BMS’ Sotyktu over Amgen’s Otezla, dermatologists continue to express a desire for additional oral agents that bring...

Long-COVID patients may have altered metabolite levels upto two years after infection - Vimarsana News

Long-COVID patients may have altered metabolite levels upto two years after infection

Mexico: A recent study published in Scientific Reports has assessed the plasma metabolome of long COVID patients two years after infection.The study led by researchers at the Autonomous University of...

Initial Management Of Patients With Rare Dermatological Disorders - Vimarsana News

Initial Management Of Patients With Rare Dermatological Disorders

Dermatology experts review available treatment options for the treatment of rare dermatological disorders.

Researchers suggest immunological medication to treat early type 1 diabetes - Vimarsana News

Researchers suggest immunological medication to treat early type 1 diabetes

An approved medication for the treatment of psoriasis is now starting a significant clinical investigation. Patients who have just received a type 1 diabetes diagnosis will test the medication. According to the theory, the medication might maintain the patient's remaining capacity to produce insulin.

Building a bridge between neuroscience and immunology - Vimarsana News

Building a bridge between neuroscience and immunology

Gloria Choi, a neuroscientist in MIT’s Department of Brain and Cognitive Sciences, studies how the immune system influences neurological development and social behavior.

Source: mit.edu